![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 36, 33478-33487, September 7, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Dipartimento di Scienze Biochimiche, Universitá degli Studi di Firenze, 50134 Firenze, Italy
Received for publication, March 14, 2001, and in revised form, May 18, 2001
| |
ABSTRACT |
|---|
|
|
|---|
Low molecular weight protein tyrosine phosphatase
(LMW-PTP) is an enzyme involved in platelet-derived growth factor
(PDGF)-induced mitogenesis and cytoskeleton rearrangement because it is
able to bind and dephosphorylate the activated receptor. LMW-PTP
presents two cysteines in positions 12 and 17, both belonging to the
catalytic pocket; this is a unique feature of LMW-PTP among all protein tyrosine phosphatases. Our previous results demonstrated that in
vitro LMW-PTP is oxidized by either H2O2
or nitric oxide with the formation of a disulfide bond between Cys-12
and Cys-17. This oxidation leads to reversible enzyme inactivation
because treatment with reductants permits catalytic activity rescue. In
the present study we investigated the in vivo inactivation
of LMW-PTP by either extracellularly or intracellularly generated
H2O2, evaluating its action directly on its
natural substrate, PDGF receptor. LMW-PTP is oxidized and inactivated
by exogenous oxidative stress and recovers its activity after oxidant
removal. LMW-PTP is oxidized also during PDGF signaling, very likely
upon PDGF-induced H2O2 production, and recovers
its activity within 40 min. Our results strongly suggest that
reversibility of in vivo LMW-PTP oxidation is
glutathione-dependent. In addition, we propose an
intriguing and peculiar role of Cys-17 in the formation of a S-S
intramolecular bond, which protects the catalytic Cys-12 from
further and irreversible oxidation. On the basis of our results we
propose that the presence of an additional cysteine near the catalytic
cysteine could confer to LMW-PTP the ability to rapidly recover its
activity and finely regulate PDGF receptor activation during both
extracellularly and intracellularly generated oxidative stress.
Protein tyrosine phosphorylation plays a key role in the
regulation of many cellular processes in eukaryotes such as cellular metabolism, proliferation, differentiation, and oncogenic
transformation (1). Accumulating evidence indicates that the
contribution of phosphotyrosine protein phosphatases
(PTPs)1 to the control of the
cell phosphorylation state is as relevant as that of phosphotyrosine
protein kinases. The PTP superfamily is composed of over 70 enzymes
that, despite very limited sequence similarity, share a common
CX5R active site motif and an identical catalytic mechanism. On the basis of their function, structure, and
sequence, PTPs can be classified in four main families: 1) tyrosine-specific phosphatases, 2) VH1-like dual specificity PTPs, 3)
the cdc25 phosphatases, and 4) the low molecular weight phosphatase (2).
The low molecular weight protein tyrosine phosphatase (LMW-PTP) is an
18-kDa enzyme that is expressed in many mammalian tissues (3). Our
previous studies on the molecular biology of LMW-PTP in NIH3T3 cells
demonstrated a well defined role of this enzyme in platelet-derived
growth factor (PDGF)-induced mitogenesis. The most relevant phenotypic
effect of LMW-PTP overexpression is a strong reduction of the cell
growth rate in response to PDGF stimulation. We have previously shown
that activated PDGF-R is a LMW-PTP substrate (4) and that LMW-PTP is
involved in the control of specific pathways triggered by PDGF-R
activation. In particular, LMW-PTP is able to modulate both
myc expression, interfering with the Src pathway, and
fos expression through a mitogen-activated protein
kinase-independent pathway mediated by the signal transducers and
activators of transcription (STAT) proteins (5). More recently, we have
found that in NIH3T3 cells LMW-PTP is constitutively localized in both
cytoplasmic and cytoskeleton-associated fractions. These two LMW-PTP
pools are differentially regulated because only the cytoskeleton-associated LMW-PTP fraction is specifically phosphorylated by c-Src after PDGF stimulation (6). As a consequence of its phosphorylation, LMW-PTP shows an average 20-fold increase in its
in vitro catalytic activity (7, 8, 9).
Cytoskeleton-associated LMW-PTP influences cell adhesion, spreading,
and migration, controlling the phosphorylation level of p190Rho-GAP, a
protein that is able to regulate Rho activity and, consequently,
cytoskeleton rearrangement in response to PDGF stimulation. Hence,
LMW-PTP is able to perform multiple roles in PDGF-induced mitogenesis:
while cytosolic LMW-PTP binds and dephosphorylates PDGF-R (4), thus
modulating part of its signaling cascade, cytoskeleton-associated
LMW-PTP acts on phosphorylated p190Rho-GAP, consequently playing a role
in PDGF-mediated cytoskeleton rearrangement (10).
Caselli et al. (11, 12) have demonstrated that in
vitro LMW-PTP is oxidized and inactivated by NO or
H2O2 and that Pi is able to protect
the enzyme from oxidation. H2O2 causes the oxidation of Cys-12 and Cys-17, the two vicinal cysteines in the catalytic pocket, as demonstrated by mass spectroscopy and radiolabeled tryptic fingerprint analysis. Furthermore, Caselli et al.
(11, 12) have demonstrated that H2O2
oxidizes Cys-12 and Cys-17 to form a disulfide bond. Treatment of
LMW-PTP with dithiothreitol restores its enzymatic activity.
Recent findings indicate that treatment with growth factors or
H2O2 induces an elevation of
tyrosine-phosphorylated proteins. This elevation can be achieved by the
activation of protein tyrosine kinases and/or inactivation of PTPs. It
has been shown that reactive oxygen species (ROS), such as O We now demonstrate that H2O2, either added
extracellularly or generated intracellularly in response to PDGF
stimulation, can cause inhibition of the activity of LMW-PTP on both
its known phosphorylated substrates PDGF-R and p190Rho-GAP. In
addition, we show that glutathione is most probably the electron donor
responsible for the reactivation of LMW-PTP after the removal of the
oxidative stress. We demonstrate that the two vicinal cysteines in the
catalytic pocket of the phosphatase confer a peculiar and reversible
redox regulation to LMW-PTP uncommon among PTP family members.
Materials--
Unless specified all reagents were obtained from
Sigma. NIH3T3 and C2C12 cells were purchased from ATCC, human
recombinant PDGF-BB was from Peprotech, the Enhanced Chemi-Luminescence
kit was from Amersham Pharmacia Biotech, all antibodies were from Santa
Cruz Biochemicals, and BCA protein assay reagent was from Pierce. 5'-F-IAA and affinity-purified rabbit antibodies to fluorescein were obtained from Molecular Probes.
Site-specific Mutagenesis and Cloning of LMW-PTP Mutants in
Eukaryotic Expression Vector--
Oligonucleotide-directed mutagenesis
was performed using the Unique Restriction Elimination Site kit from
Amersham Pharmacia Biotech. The 26-base-long target mutagenesis primer
contained an ACA codon (alanine) substituted for the original TGC codon (cysteine). The mutated LMW-PTP coding sequence was completely sequenced by the Sanger method and subcloned into the
HindIII and ApaI restriction sites of the pRcCMV
eukaryotic expression vector harboring the neomycin resistance gene.
Cell Culture and Transfections--
NIH3T3 cells were
routinely cultured in Dulbecco's modified Eagle's medium
supplemented with 10% fetal calf serum in a 5% CO2-humidified atmosphere. 10 µg of pRcCMV-wtLMW-PTP or
pRcCMV-C17A-LMW-PTP were transfected in NIH3T3 cells using the
calcium phosphate method. Stable transfected clonal cell lines were
isolated by selection with G418 (400 µg/ml). Control cell lines were
obtained by transfecting 2 µg of pRcCMVneo alone. The clonal lines
were screened for expression of the transfected genes by a)
Northern blot analysis and b) enzyme-linked immunosorbent
assay using polyclonal anti-LMW-PTP rabbit antibodies, which do not
cross-react with murine endogenous LMW-PTP.
Immunoprecipitation and Western Blot Analysis--
1 × 106 cells were seeded in 10-cm plates in Dulbecco's
modified Eagle's medium supplemented with 10% fetal calf serum. Cells were serum-starved for 24 h before receiving 30 ng/ml PDGF-BB. Cells were then lysed for 20 min on ice in 500 µl of RIPA lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl,
1% Nonidet P-40, 2 mM EGTA, 1 mM sodium
orthovanadate, 1 mM phenylmethanesulfonyl fluoride, 10 µg/ml aprotinin, 10 µg/ml leupeptin). Lysates were clarified by
centrifugation and immunoprecipitated for 4 h at 4 °C with 0.1 µg of the specific antibodies. Immune complexes were collected on
protein A-Sepharose (Amersham Pharmacia Biotech), separated by
SDS-polyacrylamide gel electrophoresis, and transferred onto
nitrocellulose (Sartorius). Immunoblots were incubated in 3% bovine
serum albumin, 10 mM Tris-HCl, pH 7.5, 1 mM
EDTA, and 0.1% Tween 20 for 1 h at room temperature, probed first
with specific antibodies, then probed with secondary antibodies
conjugated with horseradish peroxidase, washed, and developed with the
Enhanced Chemi-Luminescence kit.
Cell Lysate Fractionations--
Cell lysate fractions were
obtained as already described (6). Briefly, PDGF-stimulated NIH3T3
cells were lysed in RIPA buffer, and the lysates were clarified by
centrifugation for 30 min at 20,000 × g. Pellets were
washed twice with 1 ml of RIPA and then resuspended in complete RIPA
buffer (cRIPA), which is RIPA buffer plus 0.5% sodium deoxycholate and
0.1% sodium dodecylsulfate, by shaking for 1 h at room
temperature and clarifying by centrifugation at 20,000 × g for 30 min. RIPA or cRIPA fractions were then used for
immunoprecipitation analysis.
PTP Activity Assay--
The PTP activity was measured as
previously reported (7). Briefly, 1.5 × 106 cells
were collected in 300 µl of 0.1 M sodium acetate, pH 5.5, 10 mM EDTA, 1 mM In Vitro Labeling with 5'-F-IAA--
Affinity-purified wtLMW-PTP
was obtained using a procedure reported elsewhere (19). 1 µg of the
purified enzyme was incubated in a final volume of 20 µl at 37 °C
in 50 mM buffers of the indicated pH (sodium acetate for pH
5.5, MES for pH 6.5, and Tris-HCl for pH 7.5).
H2O2 was added at the concentration of 0.2 or 2 mM, and the mixture was incubated for an additional 10 min
at 37 °C. After the addition of 20 µM 5'-F-IAA from
freshly prepared stock in dimethylformamide, the mixture was incubated
for an additional 10 min. The labeling reaction was stopped by the
addition of 2× SDS sample buffer.
In Vivo 5'-F-IAA Labeling--
Cells were lysed directly in RIPA
buffer at pH 7.5, and 5'-F-IAA was added from freshly prepared stock to
a final concentration of 5 µM. The lysates were
maintained for 1 h at 4 °C for the labeling step and then were
treated for immunoprecipitation with anti-fluorescein antibodies.
Measurement of Intracellular ROS--
2 × 105
cells were plated in 6-cm plates in standard culture medium,
serum-starved for 24 h, and then stimulated with 30 ng/ml PDGF-BB.
20 µg/ml 2',7'-dichlorodihydrofluorescein diacetate, an
oxidant-sensitive fluorescent dye, were added 5 min before analysis.
Cells were then rapidly detached from the substrate by trypsinization
and analyzed immediately by flow cytometry using a Becton Dickinson
FACScan flow cytometer equipped with an argon laser lamp (FL-1;
emission, 480 nm; band pass filter, 530 nm).
Regulation of LMW-PTP Activity on PDGF Receptor during
Extracellularly Generated Oxidative Stress--
As already reported
LMW-PTP is oxidized in vitro by H2O2
and NO (11, 12) in its catalytic site cysteines 12 and 17. To study if
the generation of an oxidative stress in vivo could lead to
LMW-PTP oxidation, thus influencing its catalytic activity, we have
used the NIH3T3 fibroblast cell line overexpressing wtLMW-PTP. We have
quantitated the LMW-PTP activity directly on activated PDGF-R because
we previously reported that the tyrosine-phosphorylated receptor is an
in vivo natural substrate for LMW-PTP (4). We immunoprecipitated the PDGF-R from cells and evaluated its tyrosine phosphorylation level by anti-phosphotyrosine immunoblotting as an
indication of the LMW-PTP in vivo activity. We exposed
NIH3T3 cells, which were either expressing wtLMW-PTP or
mock-transfected, to an exogenous oxidative stress generated by adding
100 milliunits/ml glucose oxidase (G/O) to the culture medium. It has
been reported that after 10 min of treatment
H2O2 concentration reaches a steady state level
of 30 µM (20). Fig.
1A shows the PDGF-R
phosphorylation level in mock-transfected and wtLMW-PTP-expressing
cells during G/O treatment. Dephosphorylation of agonist-activated
PDGF-R by ectopically expressed wtLMW-PTP was almost completely blocked by the oxidative stress. The same results were obtained using 0.1 mM sodium pervanadate as the oxidant (Fig.
1B). It has been reported that although sodium orthovanadate
is a competitive inhibitor for phosphotyrosine phosphatase, its
oxidized form pervanadate is a strong oxidant of the PTPs active site
cysteine (21).
We have previously demonstrated that LMW-PTP exists in two different
cellular pools: a cytosolic pool, which is recruited to the membrane
upon PDGF stimulation acting directly on PDGF-R, and a second pool
anchored to the cytoskeleton that acts on a different substrate,
p190Rho-GAP (10). LMW-PTP is thus able to influence cell growth through
PDGF-R dephosphorylation and cytoskeleton rearrangement through Rho
regulation. The results shown in Fig. 1C demonstrate that
H2O2 can down-regulate LMW-PTP activity on
p190Rho-GAP as well as on PDGF-R, suggesting a general and strong
action of oxidative stress on both cytosolic and
cytoskeleton-associated LMW-PTP pools.
Furthermore we were interested in directly evaluating the influence of
an exogenous oxidative stress on LMW-PTP activity, using a synthetic
substrate, para-nitrophenylphosphate (PNPP), in an ex
vivo assay. Fig. 1D shows the results on G/O-stressed cells. The PTP activity of wtLMW-PTP-expressing cells is strongly inhibited by H2O2 treatment, confirming the
results obtained with phosphorylated PDGF-R and p190Rho-GAP. Caselli
et al. (11, 12) have demonstrated that LMW-PTP is oxidized
in vitro by both H2O2 and NO and is
able to rescue its catalytic activity after treatment with
reducing agents. It is interesting to note that further treatment with
catalase for 10 min (to remove H2O2) led to a
complete recovery of LMW-PTP activity (Fig. 1D), indicating
that in the cell LMW-PTP is efficiently reduced again after removal of
the oxidant.
To analyze whether the oxidized wtLMW-PTP is able to recover its
catalytic activity in vivo, we evaluated the wtLMW-PTP
activity on PDGF-R after the removal of the oxidative stress. After 10 min of G/O and PDGF treatment the produced H2O2
was removed by adding 1 µg/ml catalase to the medium. The activity of
wtLMW-PTP was quantitated by anti-phosphotyrosine immunoblotting of
anti-PDGF-R immunoprecipitates as above. Band intensities were
quantitated by analytical software, and the results are shown in Fig.
2A. Our data show that 20 min
after H2O2 removal the level of PDGF-R phosphorylation was comparable with that of the untreated control, suggesting that wtLMW-PTP is able to recover its catalytic activity on
PDGF-R. Hence, in vivo the oxidation of LMW-PTP active site cysteines is followed by a reduction process, which permits the recovery of the activity of the phosphatase on PDGF-R. To study the
reactivation mechanism of oxidized LMW-PTP we analyzed the role of the
redox cellular system based on reduced glutathione, which has been
shown to be involved in the safety mechanism of various cell molecules
(22). We reduced the availability of cellular reduced glutathione by
using a strong depleting agent, diethyl maleate (DEM). NIH3T3
cells overexpressing wtLMW-PTP were pretreated for 1 h with 0.2 mM DEM. This treatment led to a 90% decrease of the level
of free reduced glutathione (data not shown). Fig. 2B shows
the tyrosine phosphorylation level of the activated PDGF-R from
oxidized and non-oxidized wtLMW-PTP-expressing cells pretreated with
DEM. The depletion of reduced glutathione severely impaired the rescue
of oxidized wtLMW-PTP activity after H2O2 removal, suggesting a central role of this reducing agent in the reduction/reactivation of LMW-PTP.
Oxidative Inactivation of LMW-PTP during PDGF
Signaling--
Stimulation of a variety of cell surface receptors,
including those of growth factors such as epidermal growth factor and PDGF, induces a transient increase in the intracellular concentration of H2O2 (23, 24). In fact, the removal of
cellular H2O2 by catalase treatment blocks
PDGF-mediated signal transduction. In this context it is possible that
LMW-PTP is oxidized during PDGF signaling and that this oxidation
transiently influences its catalytic action on PDGF-R.
LMW-PTP contains eight cysteine residues, which do not appear to form
disulfide bonds. In fact, the reduced state of all the sulfhydryl
groups of LMW-PTP has been demonstrated by our group and others (25,
26). Both cysteines in positions 12 and 17 are conserved among the
LMW-PTP subfamily, thus suggesting an important role for both residues.
We have already demonstrated that Cys-12 is the essential cysteine
residue performing in the cysteinyl-phosphate intermediate during
catalysis, whereas Cys-17 has a role in phosphate binding in
cooperation with Arg-18 (27). Van Etten et al. (26) have
demonstrated that LMW-PTP has two reactive cysteines in the catalytic
site with a low pKa (at pH 7.52 and 9.05 for
iodoacetamide). Caselli et al. (11, 12) have demonstrated
that H2O2 and NO lead to the specific oxidation
of Cys-12 and Cys-17 in the catalytic pocket of LMW-PTP. In addition
the active site cysteines of LMW-PTP, as in other PTPs, are
specifically targeted by the sulfhydryl-modifying reagent iodoacetic
acid (25, 26). Recently an iodoacetamide-fluorescein (5'-F-IAA)
labeling method of proteins containing low pKa cysteine residues has been reported (28), and we applied this method to
study the oxidation state of LMW-PTP in vivo. We verified that in vitro the reaction of purified wtLMW-PTP with
5'-F-IAA was almost completely blocked by 0.2 mM
H2O2 (Fig.
3A) at pH 6.5-7.5, suggesting
a specificity of 5'-F-IAA for LMW-PTP active site reduced cysteines in
these conditions.
To verify whether during PDGF signaling LMW-PTP becomes oxidized at the
two catalytic cysteines, wtLMW-PTP-expressing cells were incubated for
various times with PDGF and then lysed in RIPA buffer, pH 7.0, containing 5 µM 5'-F-IAA according to Zhang et al. (26). LMW-PTP was then immunoprecipitated from lysates, and
anti-fluorescein immunoblotting was performed. The result is shown in
Fig. 3B. LMW-PTP was strongly oxidized during PDGF signaling, reaching a maximum 10 min after stimulation with PDGF. The
oxidation was followed by a new reduction, which reached the level of
unstimulated cells 40 min after stimulation, suggesting that the
oxidation/inactivation of LMW-PTP is transient and the enzyme is
reactivated after the removal of the oxidants by endogenous mechanisms.
The blot was reprobed with anti-LMW-PTP antibodies, and band
intensities of both anti-fluorescein and anti-LMW-PTP immunoblots were
quantitated. The ratio between these two values is reported in Fig.
3C as percentage of LMW-PTP reduction, allowing us to
demonstrate that about 80% of LMW-PTP is already oxidized 2 min after
the stimulation with PDGF and that oxidation becomes almost complete
after 10 min. Moreover, within 40 min about 70% of LMW-PTP recovered
the reduced state. Moreover, in a parallel experiment, we quantitated
the LMW-PTP activity of immunoprecipitated LMW-PTP in PDGF-treated
cells by using an enzymatic assay with PNPP as substrate. The
results, reported in Fig. 3D, demonstrate that the oxidation
of the phosphatase temporally coincided with enzyme inactivation while
the re-reduction was concomitant with the rescue of catalytic activity.
Interestingly, oxidation/inactivation of LMW-PTP reached the maximum
after 10 min together with the ROS production peak, which was measured
by 2',7'-dichlorodihydrofluorescein diacetate labeling (data not shown).
It has been reported that the H2O2 transient
increase observed after growth factor stimulation is due to the
activity of a nonphagocytic NADPH oxidase (29). To assess whether the
oxidation of LMW-PTP during PDGF signaling is really due to
endogenously produced H2O2, we used a strong
inhibitor of the NADPH oxidase complex, diphenyl iodide (DPI).
wtLMW-PTP-expressing cells were pretreated or not for 30 min with 10 µM DPI, and the oxidation of LMW-PTP was assayed by
5'-F-IAA labeling and anti-fluorescein immunoblotting as described
above (Fig. 3E). In addition, DPI pretreatment caused a
decrease of the PDGF receptor phosphorylation level in agreement with
the absence of phosphatase inhibition (data not shown). The result
demonstrates that the oxidation of LMW-PTP after PDGF treatment is
impaired by the inhibition of NADPH oxidase by DPI, suggesting a
central role of endogenously produced H2O2 in
LMW-PTP oxidation.
To confirm the redox regulation of LMW-PTP during PDGF signaling, we
assayed the redox state of endogenous phosphatase in NIH3T3 cells and
in C2C12 myoblasts. Unfortunately the level of LMW-PTP in
growing NIH3T3 cells is almost undetectable but rapidly increases when
cells reach confluence (3).2
On the other hand, C2C12 mouse myoblasts naturally express a level of
LMW-PTP higher than that in NIH3T3 cells. For these reasons, we have
analyzed the redox state of endogenous LMW-PTP in PDGF-stimulated confluent NIH3T3 cells and in C2C12 cells. The oxidation of LMW-PTP was
assayed by 5'-F-IAA labeling. LMW-PTP was then
immunoprecipitated from lysates, and anti-fluorescein immunoblotting
was performed. The result is shown in Fig.
4A. Endogenous LMW-PTP was
strongly oxidized after PDGF treatment. Moreover, the oxidation was
followed by a new reduction thereafter. These data confirm that the
oxidation/inactivation of LMW-PTP (either endogenous or overexpressed)
is transient, and the enzyme is reduced/reactivated after the removal
of the oxidants.
In addition, in a parallel experiment we quantitated PTP activity in
anti-LMW-PTP immunoprecipitates after PDGF treatment. Endogenous
LMW-PTP from C2C12 cells was immunoprecipitated from PDGF-stimulated
cells, and enzyme activity is shown in the plot of Fig. 4B.
The data confirm that the oxidation of LMW-PTP during PDGF stimulation
is followed by enzyme inactivation, while the re-reduction thereafter
is accompanied by enzyme reactivation.
Furthermore, we studied the role of the reactivation of LMW-PTP during
PDGF signaling. For this purpose, we blocked the
glutathione-dependent cellular system of oxidized protein
reduction by using an inhibitor of the Role of Cys-17 in Rescue of LMW-PTP Activity on PDGF Receptor after
Removal of Oxidative Stress--
It has been reported both in
vivo and in vitro that the oxidation of a sulfhydryl
group to sulfenic acid (SOH) rapidly and spontaneously evolved into
further oxidation products such as sulfinic acid and sulfonic
(SO2 and SO3) (22). The milder oxidation to
sulfenic acid of the catalytic site cysteine of a phosphatase is
sufficient to inactivate the enzyme, although the reversibly of the
reaction (i.e. the reduction to SH) is yet possible. The further oxidation states (SO2 and SO3) are
probably terminal products that do not permit cellular reduction
systems to operate on them, thus leading to inactive modified proteins
(see Scheme 1, where cat. is
catalytically). In this light, only a milder oxidation could be
intended as a possible redox functional regulation.
To study the role of the cysteine in position 17 on the
oxidation/inactivation and reduction/reactivation processes of LMW-PTP, we treated NIH3T3 cells expressing wtLMW-PTP or C17A-LMW-PTP with PDGF
and G/O for 10 min (Fig. 6B), and then we removed the
oxidative stress by catalase treatment for an additional 30 min (Fig.
6C). The level of the PDGF-R tyrosine phosphorylation
was quantitated by anti-phosphotyrosine immunoblotting, and band
intensities were revealed by software analysis. The results show that
both the wild type enzyme and the mutant C17A-LMW-PTP were inactivated by H2O2 (Fig. 6B). On the contrary,
although wtLMW-PTP recovered its activity 30 min after the removal of
the oxidative stress, the rescue of the C17A-LMW-PTP
H2O2-inactivated mutant was severely impaired
upon catalase treatment (Fig. 6C). These findings are in
agreement with the results of Caselli et al. (11, 12) who have shown that both LMW-PTP catalytic site cysteines are oxidized by
H2O2 and NO forming a disulfide bond and
suggest that the specific role of Cys-17 is in the
reactivation/reduction of LMW-PTP and not in the
inactivation/oxidation. To better assess these findings we repeated the
same experiment as above but directly evaluated LMW-PTP-specific
activity on PNPP (Fig. 6D). The results again demonstrate
that C17A-LMW-PTP was inactivated by oxidation, as was wtLMW-PTP
(although to a lower extent), but was completely unable to recover its
activity on PNPP upon removal of the oxidative stress.
We proposed that the same Cys-17-mediated redox regulation of
inactivation/reactivation of LMW-PTP is achieved during the PDGF
signaling-dependent oxidative stress mediated by
H2O2 production. To test this hypothesis, we
analyzed the redox state of LMW-PTP by in vivo 5'-F-IAA
labeling and anti-fluorescein immunoblotting after PDGF treatment of
wt- and C17A-LMW-PTP-expressing cells (Fig.
7). The results show again that the
position 17 was irrelevant in the oxidation of LMW-PTP after PDGF
stimulation. On the contrary, Cys-17 was essential in the reduction
process of LMW-PTP, which leads to enzyme reactivation.
On the basis of these data we propose that LMW-PTP is able to rescue
its enzymatic activity upon GSH-dependent reduction of the
disulfide bridge between Cys-12 and Cys-17 that is formed upon
oxidation. This disulfide bond can be considered as a protection system
of LMW-PTP against further oxidation. In fact, protection of the
catalytic Cys-12 from oxidation states higher than sulfenic acid of the
catalytic Cys-12 could be achieved either by GSH mixed disulfide or by
an intramolecular Cys-12-Cys-17 disulfide. The impairment of oxidized
C17A-LMW-PTP reduction (which still possess a functional Cys-12)
excludes the possibility of a Cys-12-GSH mixed disulfide as a
protection mechanism and supports our hypothesis of the formation of an
intramolecular Cys-12-Cys-17 bridge.
On the basis of the growing evidence of the requirement of
endogenously produced oxidants during growth factor signal transduction (13, 27, 28), we investigated in vivo the possible redox regulation of LMW-PTP by H2O2 during PDGF
stimulation in NIH3T3 cells. It has been reported that the
H2O2 produced upon growth factor stimulation is
really a cellular second messenger directly influencing many signal
transducers such as the STAT proteins, p70 s6k, protein kinase D, and
PTPs (33-36). We have already demonstrated that LMW-PTP is a key
regulator of PDGF-R phosphorylation upon recruitment to the membrane
when cells are stimulated with the growth factor (5, 6, 10).
In this article we first show that LMW-PTP was oxidized in
vivo by an exogenous oxidative stress such as
H2O2 produced by G/O or sodium pervanadate. We
have already demonstrated that in NIH3T3 cells LMW-PTP is active on
phosphorylated PDGF-R and on p190Rho-GAP, thus influencing both mitosis
rate and cytoskeleton rearrangement. Herein, we quantitated the
in vivo activity of LMW-PTP directly on its natural
phosphorylated substrates and demonstrate that the oxidation of LMW-PTP
led to the inactivation of the enzyme preventing dephosphorylation of
both PDGF-R (Fig. 2, A and B) and p190Rho-GAP
(Fig. 2B). We have previously demonstrated that LMW-PTP is
distributed in the cell in two different pools, a cytosolic pool, which
acts on PDGF-R, and a cytoskeleton-associated pool, which is active on
p190Rho-GAP (10). In agreement with the extremely rapid diffusion of
small oxidants such as H2O2 among cellular
compartments, we observed a strong inhibition of LMW-PTP (via
oxidation) on both activated PDGF-R and phosphorylated
p190Rho-GAP.
The inactivation of LMW-PTP by oxidation is reversible in
vitro upon reductant treatment with such agents as dithiothreitol (11, 12). Herein we show that LMW-PTP was able to rescue its catalytic
activity in vivo on its substrate PDGF-R after the removal of the oxidative stress. The reversibility of oxidation and the consequent recovery of enzymatic activity are generally recognized as
key points in the redox regulation of a protein. In fact, it has been
widely discussed that protein oxidation should have two different
meanings in cell behavior. Oxidation of the protein backbone or the
simple oxidation of methionine and/or cysteine residues could lead to
direct protein fragmentation or to irreversibly oxidized "dead"
products (37). On the other hand, regulated oxidation of amino acid
side chains and in particular of cysteine residues should be considered
a reversible functional regulation of proteins because the oxidation
might be reversed by the redox cellular systems (thioredoxin and
GSH/glutaredoxin). Herein, we show that the reduction process that
permits the recovery of LMW-PTP activity was dependent on the cellular
reduced glutathione content as indicated by the data obtained using BSO
or DEM to deplete glutathione (Figs. 2 and 5). Thioredoxin/thioredoxin
reductase/NADPH and glutaredoxin/glutathione/glutathione
reductase/NADPH are the two major redox cellular systems (38). Our
findings indicate that in vivo the LMW-PTP reactivation is
under the control of the glutaredoxin/glutathione/glutathione
reductase/NADPH system.
Moreover, we have shown that the redox regulation of LMW-PTP in
vivo activity i) was active upon PDGF stimulation, ii) was performed by the endogenously produced H2O2,
and iii) was required for LMW-PTP dephosphorylation of PDGF-R itself.
In fact, we demonstrate that upon PDGF treatment almost 80% of LMW-PTP
was oxidized and inhibited after 10 min and that after 45 min almost
70% of the phosphatase was reduced and had recovered its catalytic
activity. Also in these conditions the reduction process was dependent
on the availability of reduced glutathione because the reduction process was impaired by BSO treatment (Fig. 7). In addition, we have
shown that this redox regulation was active also on the endogenous enzyme and hence that was not a particular feature of overexpressed LMW-PTP.
It has been proposed that the transient increase of ROS observed in
response to growth factor administration is due to the induced
activation of a membrane NADPH oxidase complex (39). This event is
dependent on the administration of PDGF and is probably under the
control of the signal transduction pathway of phosphatidylinositol 3-kinase (40). We have shown that the oxidation of LMW-PTP was performed by an endogenously produced oxidative stress as indicated by
the use of DPI, an inhibitor of the NADPH oxidase. This treatment clearly prevented the oxidation of LMW-PTP in response to PDGF (Fig.
3D).
Furthermore, our data suggest that the redox regulation of LMW-PTP
during PDGF stimulation was required for PDGF-R dephosphorylation. In
fact, the inhibition of the recovery of the LMW-PTP catalytic activity
by reduction with glutathione-depleting agents such as BSO severely
impaired the action of LMW-PTP on phosphorylated receptor. These data,
together with the time-dependent oxidation/inactivation and
reduction/reactivation of LMW-PTP upon PDGF stimulation, indicate a
specific role of the inhibition of LMW-PTP during PDGF-R signal transduction. In fact, the phosphatase was oxidized/inactivated (up to
80%) at the very beginning of agonist stimulation and
reduced/reactivated later when switching off of the receptor signal is
required. Lee et al. (14) have proposed a different
explanation for a similar behavior of PTP1B during epidermal growth
factor stimulation. They propose that the growth factor stimulation
alone may not be sufficient to increase the steady state level of
protein tyrosine phosphorylation in the cell and that concurrent
inhibition of protein tyrosine phosphatases by
H2O2 might also be required (14). This second
hypothesis is supported by data about the PDGF-R activation by UV rays
through PTP inactivation/oxidation (41). PTP inhibition permits the
transduction of the signal through the maintenance of a high receptor
phosphorylation level. Hence, PTPs could be seen either as regulators
of the turning off of the growth factor signal or as concurrent
activators of the receptor phosphorylation. Our data on BSO impairment
of LMW-PTP action on PDGF-R dephosphorylation suggest that the main
action of the phosphatase is after the redox reactions upon PDGF
stimulation and hence in the late phase of the receptor signaling.
The function of glutathione in the redox regulation of PTP1B is
to protect the sulfenic derivative from further oxidation because it
can easily be oxidized to form the irreversible sulfinic and sulfonic
products. In fact, cysteine sulfenic acids are highly unstable and
readily undergo condensation with a thiol. In the presence of reduced
glutathione, the sulfenic derivative can be converted to a more stable
S-thiolated product (15). This reaction prevents a
further oxidation to sulfinic or sulfonic acid. This is a general
mechanism that should operate on every PTP that possesses the catalytic
cysteine. The different behavior of glutathione in the protection of
PTP1B or LMW-PTP from further oxidation could be because of differences
in the structures of the catalytic sites of the two phosphatases. In
fact, the PTP1B active site cleft is surrounded by positively charged
lysine residues, which could interact with the negatively charged
glutathione. On the other hand, the LMW-PTP active site crevice is rich
in aromatic residues, a structure that should not facilitate the entry
of GSH.
We propose that LMW-PTP is able to undergo a different mechanism
because of the presence of an additional cysteine in the catalytic
site, which can form an intramolecular S-S bridge. This intramolecular S-S bond between Cys-12 and Cys-17 has only been observed in vitro in mass spectroscopy-analyzed of
NO-oxidized LMW-PTP (11). In fact, the C17A-LMW-PTP mutant
still possesses the catalytic cysteine in position 12, which could be
glutathionated and thus preserved from further oxidation. On
the contrary, we observed a dramatic decrease in the catalytic activity
rescue of the C17A-LMW-PTP mutant upon reduction, suggesting a key role of the intramolecular S-S disulfide in the protection of LMW-PTP from
excessive oxidation. We suggest that the presence of this additional
cysteine in the catalytic site, which allows intramolecular S-S bond
formation, confers a peculiar rapidity and efficiency in the redox
regulation of the phosphatase. The formation of an intramolecular
disulfide bond in Yab1 transcription factor has already been proposed
to be responsible for the rapid response to the stress condition in
H2O2 sensing (31).
In conclusion, we propose that LMW-PTP has a peculiar safety mechanism
during its redox regulation, based on the formation of an
intramolecular disulfide bond between the two catalytic cysteines, that
could allow a rapid and efficient recovery of catalytic activity during
both extracellularly and intracellularly generated oxidative stress,
thus leading to a fine tuning of PDGF-R activation.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-mercaptoethanol and
sonicated for 10 s. The lysates were clarified by centrifugation,
and 50 µl were used in the PTP activity assay with 50 µl of 10 mM para-nitrophenylphosphate, at 37 °C for 30 min. The production of p-nitrophenol was measured colorimetrically at 410 nm. The results were normalized on the basis of
total protein content. Furthermore, PTP activity was measured in
anti-LMW-PTP immunoprecipitates in 300 µl of 0.1 M sodium
acetate, pH 5.5, 10 mM EDTA, 1 mM
-mercaptoethanol at 37 °C for 15 and 45 min for wtLMW-PTP or
C2C12 myoblasts, respectively.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (32K):
[in a new window]
Fig. 1.
Inhibition of LMW-PTP activity during
extracellularly generated oxidative stress. 1 × 106 NIH3T3 cells that were either overexpressing wtLMW-PTP
or mock-transfected were serum-starved for 24 h and then
stimulated with 30 ng/ml PDGF-BB and 100 milliunits/ml G/O (panel
A) or 0.1 mM pervanadate (panel B). PDGF-R
was immunoprecipitated. The anti-phosphotyrosine immunoblot is shown.
The anti-phosphotyrosine immunoblot of anti-p190Rho-GAP
immunoprecipitates from G/O-treated cells is shown in panel
C. The lysates were fractionated to purify the cytoskeleton
fraction as indicated under "Experimental Procedures." In
panel D the PTP-specific activity in lysates on PNPP is
shown in units/mg. Cells were serum-starved for 24 h and then
treated with PDGF for 10 min, with both G/O (G/OX) and
PDGF-BB for 10 min, or with PDGF-BB and catalase (CAT) for
10 min. Lysates were obtained as indicated under "Experimental
Procedures." C, control.

View larger version (11K):
[in a new window]
Fig. 2.
Recovery of LMW-PTP catalytic activity after
removal of the oxidative stress. 1 × 106 NIH3T3
cells overexpressing wtLMW-PTP pretreated with (panel B) or
without (panel A) DEM for 1 h were serum-starved for
24 h and then stimulated with 30 ng/ml PDGF-BB and 100 milliunits/ml G/O for 10 min. The medium was then changed, and 1 µg/ml catalase was added for an additional 20 min. PDGF-R was
immunoprecipitated, and anti-phosphotyrosine immunoblotting was
performed. The plots show the data from densitometric analysis of the
blots.

View larger version (21K):
[in a new window]
Fig. 3.
LMW-PTP oxidation during PDGF stimulation.
Panel A, anti-fluorescein immunoblot of purified LMW-PTP
oxidized in vitro by H2O2 treatment
and labeled with 5'-F-IAA. Buffer, pH, and H2O2
concentrations are indicated. Panel B, 1 × 106 NIH3T3 cells overexpressing wtLMW-PTP were
serum-starved for 24 h and then stimulated with 30 ng/ml PDGF-BB
for the indicated times (' represents minutes). The medium was not
changed, and no exogenous catalase was added. Lysates were treated with
5'-F-IAA as indicated under "Experimental Procedures." LMW-PTP was
immunoprecipitated at the indicated times, and anti-fluorescein
immunoblotting was performed. The plot in panel C shows the
data of the densitometric analysis of the anti-fluorescein blots;
controls were taken as 100%. Panel D, 1 × 106 NIH3T3 cells overexpressing wtLMW-PTP were
serum-starved for 24 h and then stimulated with 30 ng/ml PDGF-BB
for the indicated times (in minutes). LMW-PTP was immunoprecipitated,
and a PTP activity assay was performed using PNPP as substrate.
LMW-PTP activity is shown in units/mg. Panel E, 1 × 106 NIH3T3 cells were pretreated or not for 30 min with 10 µg of DPI and then treated as in panel B.

View larger version (23K):
[in a new window]
Fig. 4.
Endogenous LMW-PTP redox regulation in
response to PDGF. Panel A, confluent NIH3T3 cells or C2C12
myoblasts were serum-starved for 24 h and then stimulated with 30 ng/ml PDGF-BB for the indicated times (' represents minutes). Lysates
were treated with 5'-F-IAA as indicated under "Experimental
Procedures." LMW-PTP was immunoprecipitated, and anti-fluorescein
immunoblotting was performed. Loading equalization was performed by
immunoblotting the stripped blots with anti-LMW-PTP. Panel
B, 1 × 106 C2C12 cells were serum-starved for
24 h and then stimulated with 30 ng/ml PDGF-BB for the indicated
times (in minutes). LMW-PTP was immunoprecipitated at the indicated
times, and a PTP activity assay was performed using PNPP as
substrate. LMW-PTP activity is shown in units/mg.
-glutamylcysteine synthetase,
buthionine sulfoxide (BSO) (30). The cellular glutathione concentration
was decreased to 90% by a 24-h pretreatment of NIH3T3 cells (data not
shown). Mock-transfected and wtLMW-PTP-expressing NIH3T3 cells were
pretreated or not for 16 h with 25 mM BSO, and the
tyrosine phosphorylation level of PDGF-R was assayed by
anti-phosphotyrosine immunoblotting. The results are shown in Fig.
5. In wtLMW-PTP-expressing cells the BSO
treatment almost completely blocked the action of wtLMW-PTP on PDGF-R,
whereas in mock-transfected cells BSO was ineffective on the level of
phosphorylation of PDGF-R. These findings suggest that the
GSH-dependent reduction process on oxidized LMW-PTP after PDGF treatment is a key control event of the phosphatase activity on
PDGF-R.

View larger version (30K):
[in a new window]
Fig. 5.
Requirement of a reduction step for
dephosphorylation of PDGF-R. 1 × 106 cells of
the indicated type were pretreated or not with BSO for 16 h,
serum-starved for 24 h, and then stimulated or not with 30 ng/ml
PDGF-BB for 10 min. PDGF-R was immunoprecipitated, and the
anti-phosphotyrosine immunoblot is shown.
It has been reported very recently that in
vitro PTP1B is able to recover its catalytic activity after the
removal of the oxidative stress by the thioredoxin system (14) or by
the GSH system (15). The authors (14, 15) suggest that the
cellular reduction system could play a central role in maintaining a
low oxidation grade in PTP1B through the formation of a mixed disulfide between PTP1B and GSH. All members of the LMW-PTP subfamily have two
vicinal cysteines in positions 12 and 17, which are both in the
catalytic pocket and totally conserved among the members of the
subfamily. These two cysteines in vitro are able to form an intramolecular S-S bridge (12). We supposed that the redox functional regulation of this enzyme in vivo could be simply achieved
by the formation of an intramolecular disulfide bond between Cys-12 and
Cys-17. Mutations at the two cysteines had already been generated. Although the mutation in the Cys-12 totally inactivates the enzyme in vivo and in vitro (4), the C17A mutant retains
in vitro about 70% of its activity, suggesting a minor
involvement of this residue in the catalytic mechanism (27, 28).
To evaluate the in vivo activity of the C17A-LMW-PTP mutant,
we transfected this mutant in NIH3T3 cells. First we demonstrated that
C17A-LMW-PTP was active on phosphorylated PDGF-R. The results are
reported in Fig. 6A.
C17A-LMW-PTP retained almost 70% of the activity on the receptor with
respect to wtLMW-PTP. This finding is in agreement with the activity of
the C17A-LMW-PTP mutant measured in vitro on PNPP
(32).3

View larger version (35K):
[in a new window]
Fig. 6.
Role of Cys-17 in the redox regulation of
LMW-PTP during extracellularly generated oxidative stress. Panel
A, 1 × 106 NIH3T3 cells overexpressing wtLMW-PTP
or C17A-LMW-PTP were serum-starved for 24 h and then stimulated or
not with 30 ng/ml PDGF-BB for 10 min (10'). PDGF-R was
immunoprecipitated. The anti-phosphotyrosine immunoblot is shown.
Panel B, 1 × 106 NIH3T3 cells
overexpressing wtLMW-PTP (wt) or C17A-LMW-PTP
(C17A) were serum-starved for 24 h and then stimulated
with 30 ng/ml PDGF-BB and 100 milliunits/ml G/O for 10 min. Panel
C, cells were treated first as in panel B, the medium
was changed, and then 1 µg/ml of catalase was added for an additional
30 min. PDGF-R was immunoprecipitated, and anti-phosphotyrosine
immunoblotting was performed. The histogram shows the data from the
densitometric analysis of the blots. Panel D, cells were
treated as in panels B and C, but fresh lysates
were used for an in vitro PTP assay using PNPP as substrate.
PTP-specific activity is shown in units/mg. C, control;
G/OX, G/O; cat, catalase.

View larger version (18K):
[in a new window]
Fig. 7.
Role of Cys-17 in the redox regulation of
LMW-PTP during PDGF signaling. 1 × 106 NIH3T3
cells overexpressing wtLMW-PTP or C17A-LMW-PTP were pretreated or not
with BSO for 16 h, serum-starved for 24 h, and then
stimulated with 30 ng/ml PDGF-BB for 10 min. The medium was then
changed, and 1 µg/ml catalase (cat) was added when
indicated for an additional 20 min. LMW-PTP was immunoprecipitated, and
anti-fluorescein immunoblotting was performed.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
FOOTNOTES |
|---|
* This work was supported by Consiglio Nazionale delle Ricerche Grant 97.03810.CT14, target project on Biotechnology, Strategic project "Controlli post-trascrizionali dell'espressione genica," Ministero dell'Universitá e della Ricerca Scientifica e Tecnologica-Consiglio Nazionale delle Ricerche Biotechnology Program Grant L.95/95, by the Italian Association for Cancer Research (AIRC), and in part by the Ministero della Università e Ricerca Scientifica e Tecnologica, European Community Grant ERB-Bo4-CT96-0517, and Cassa di Risparmio di Firenze.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dipartimento di
Scienze Biochimiche, viale Morgagni 50, 50134 Firenze, Italy. Tel.:
39-055-413765; Fax: 39-055-4222725; E-mail:
raugei@scibio.unifi.it.
Published, JBC Papers in Press, June 27, 2001, DOI 10.1074/jbc.M102302200
2 P. Chiarugi, unpublished observations.
3 P. Chiarugi, T. Fiaschi, M. L. Taddei, D. Talini, E. Giannoni, G. Raugei, and G. Ramponi, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: PTP, protein tyrosine phosphatase; LMW-PTP, low molecular weight protein tyrosine phosphatase; 5'-F-IAA, 5'-fluoresceinated iodoacetamide; BSO, buthionine sulfoxide; DEM, diethyl maleate; DPI, diphenyl iodide; G/O, glucose oxidase; PDGF, platelet-derived growth factor; PDGF-R, PDGF receptor; PNPP, para-nitrophenylphosphate; wtLMW-PTP, wild type LMW-PTP; MES, 4-morpholineethanesulfonic acid; ROS, reactive oxygen species.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Van der Geer, P., Hunter, T., and Lindberg, R. (1994) Annu. Rev. Cell Biol. 10, 251-337 |
| 2. | Fauman, E. B., and Saper, M. A. (1996) Trends Biochem. Sci. 21, 413-417 |
| 3. | Ramponi, G. (1994) Adv. Protein Phosphatases 8, 1-25 |
| 4. | Chiarugi, P., Cirri, P., Raugei, G., Camici, G., Dolfi, F., Berti, A., and Ramponi, G. (1995) FEBS Lett. 372, 49-53 |
| 5. | Chiarugi, P., Cirri, P., Marra, F., Raugei, G., Fiaschi, T., Camici, G., Manao, G., Romanelli, R. G., and Ramponi, G. (1998) J. Biol. Chem. 273, 6776-6785 |
| 6. | Cirri, P., Chiarugi, P., Taddei, L., Raugei, G., Camici, G., Manao, G., and Ramponi, G. (1998) J. Biol. Chem. 273, 32522-32527 |
| 7. | Bucciantini, M., Chiarugi, P., Cirri, P., Taddei, L., Stefani, M., Raugei, G., Nordlund, P., and Ramponi, G. (1999) FEBS Lett. 456, 73-78 |
| 8. | Rigacci, S., Degl'Innocenti, D., Bucciantini, M., Cirri, P., Berti, A., and Ramponi, G. (1996) J. Biol. Chem. 271, 1278-1281 |
| 9. | Tailor, P., Gilman, J., Williams, S., Couture, C., and Mustelin, T. (1997) J. Biol. Chem. 272, 5371-5374 |
| 10. | Chiarugi, P., Cirri, P., Taddei, L., Giannoni, E., Camici, G., Manao, G., Raugei, G., and Ramponi, G. (2000) J. Biol. Chem. 275, 4640-4646 |
| 11. | Caselli, A., Chiarugi, P., Camici, G., Manao, G., and Ramponi, G. (1995) FEBS Lett. 374, 249-252 |
| 12. | Caselli, A., Marzocchini, R., Camici, G., Manao, G., Moneti, G., Pieraccini, G., and Ramponi, G. (1998) J. Biol. Chem. 273, 32554-32560 |
| 13. | Kamata, H., and Hirata, H. (1999) Cell. Signal. 11, 1-14 |
| 14. | Lee, S. R., Kwon, K. S., Kim, S. R., and Rhee, S. G. (1998) J. Biol. Chem. 273, 15366-15372 |
| 15. | Barrett, W. C., Degnore, J. P., Konig, S., Fales, H. M., Keng, Y. F., Zang, Z. Y., Yim, M. B., and Chock, P. B. (1999) Biochemistry 38, 6699-6705 |
| 16. | Zhang, Z. Y., and Dixon, J. E. (1994) Adv. Enzymol. Relat. Areas Mol. Biol. 68, 1-36 |
| 17. | Hecht, D., and Zick, Y. (1992) Biochem. Biophys. Res. Commun. 188, 773-779 |
| 18. | Denu, J. M., and Tanner, K. G. (1998) Biochemistry 37, 5633-5642 |
| 19. | Cirri, P., Fiaschi, T., Chiarugi, P., Camici, G., Manao, G., Raugei, G, and Ramponi, G. (1996) J. Biol. Chem. 271, 2604-2607 |
| 20. | Tirosh, A., Potashnik, R., Bashan, N., and Rudich, A. (1999) J. Biol. Chem. 274, 10595-10602 |
| 21. | Huyer, G., Liu, S., Kelly, J., Moffat, J., Payette, P., Kennedy, B., Tsatrailis, G., Gresser, M. J., and Ramachandran, C. (1997) J. Biol. Chem. 272, 843-851 |
| 22. | Claiborne, A., Yeh, J. I., Mallett, T. C., Luba, J., Crane, E. J., Charrier, V., and Parsonage, D. (1999) Biochemistry 38, 15407-15416 |
| 23. | Bae, Y. S., Kang, S. W., Seo, M. S., Baines, I. C., Teckle, E., Chock, P. B., and Rhee, S. G. (1997) J. Biol. Chem. 272, 217-221 |
| 24. | Sundaresan, M., Yu, Z., Ferrans, V. J., Irani, K., and Finkel, T. (1995) Science 270, 296-232 |
| 25. | Camici, G., Manao, G., Cappugi, G., Modesti, A., Stefani, M., and Ramponi, G. (1989) J. Biol. Chem. 264, 2560-2567 |
| 26. | Zhang, Z. Y., Davis, J. P., and Van Etten, R. L. (1992) Biochemistry 31, 1701-1711 |
| 27. | Cirri, P., Chiarugi, P., Camici, G., Manao, G., Raugei, G., Cappugi, G., and Ramponi, G. (1993) Eur. J. Biochem. 214, 647-657 |
| 28. | Wu, Y., Kwon, K. S., and Rhee, S. G. (1998) FEBS Lett. 440, 11-115 |
| 29. | Babior, B. M. (1999) Blood 93, 1464-1476 |
| 30. | Biaglow, J. E., Donaue, J., Tuttle, S., Held, K., Chrestensen, C., and Meyal, J. (2000) Anal. Biochem. 281, 77-86 |
| 31. | Delaunay, A., Isnard, A. D., and Toledano, M. B. (2000) EMBO J. 19, 5157-5166 |
| 32. | Davis, J. P., Zhou, M. M., and Van Etten, R. L. (1994) J. Biol. Chem. 269, 8734-8740 |
| 33. | Carballo, M., Conde, M., Bekay, R., Martin-Nieto, J., Camacho, M. J., Monteseirin, J., Conde, J., Bedoja, F. J., and Sobrino, F. (1999) J. Biol. Chem. 274, 17580-17586 |
| 34. | Bae, G., Seo, D., Kwon, H., Lee, H., Hong, S., Lee, Z., Ha, K., Lee, H., and Han, J. (1999) J. Biol. Chem. 274, 32596-32602 |
| 35. | Sun, X., Majumbder, P., Shyoia, H., Wu, F., Kumar, S., Weilchselbaum, R., Kharbanda, S., and Kufe, D. (2000) J. Biol. Chem. 275, 17237-17240 |
| 36. | Waldron, R. T., and Rozengurt, E. (2000) J. Biol. Chem. 275, 17114-17121 |
| 37. | Berlett, B. S., and Stadtman, E. R. (1997) J. Biol. Chem. 272, 20313-20316 |
| 38. | Mustacich, D., and Powis, G. (2000) Biochem. J. 346, 1-8 |
| 39. | Pagano, P. J., Clark, J. K., Cifuentes-Pagano, J. K., Clark, S. M., Callis, J. M., and Quinn, M. T. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 14483-14488 |
| 40. | Bae, Y. S., Sung, J., Kim, O., Kim, Y., Hur, K. C., Kazlauskas, A., and Rhee, S. G. (2000) J. Biol. Chem. 275, 10527-10531 |
| 41. | Gross, S., Knebbel, A., Tenev, T., Neininger, A., Gaestel, M., Herrlich, P., and Bohmer, F. (1999) J. Biol. Chem. 274, 26378-26386 |
This article has been cited by other articles:
![]() |
H. Choi, K. Aboulfatova, H. J. Pownall, R. Cook, and J.-f. Dong Shear-induced Disulfide Bond Formation Regulates Adhesion Activity of von Willebrand Factor J. Biol. Chem., December 7, 2007; 282(49): 35604 - 35611. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mancini, S. Rigacci, A. Berti, C. Balduini, and M. Torti The low-molecular-weight phosphotyrosine phosphatase is a negative regulator of Fc{gamma}RIIA-mediated cell activation Blood, September 15, 2007; 110(6): 1871 - 1878. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shinohara, W.-H. Shang, M. Kubodera, S. Harada, J. Mitsushita, M. Kato, H. Miyazaki, H. Sumimoto, and T. Kamata Nox1 Redox Signaling Mediates Oncogenic Ras-induced Disruption of Stress Fibers and Focal Adhesions by Down-regulating Rho J. Biol. Chem., June 15, 2007; 282(24): 17640 - 17648. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kanda, Y. Ihara, H. Murata, Y. Urata, T. Kono, J. Yodoi, S. Seto, K. Yano, and T. Kondo Glutaredoxin Modulates Platelet-derived Growth Factor-dependent Cell Signaling by Regulating the Redox Status of Low Molecular Weight Protein-tyrosine Phosphatase J. Biol. Chem., September 29, 2006; 281(39): 28518 - 28528. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Terada Specificity in reactive oxidant signaling: think globally, act locally J. Cell Biol., August 28, 2006; 174(5): 615 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Clempus and K. K. Griendling Reactive oxygen species signaling in vascular smooth muscle cells Cardiovasc Res, July 15, 2006; 71(2): 216 - 225. [Abstract] |